Fig. 3From: HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing dataMRD trend comparison. MRD trend obtained from ASO q-PCR (blue line) and HashClone (red line) of Patient B and E of Pilot1 and patient A and E of Pilot2 Back to article page